Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I, Open-Label, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intra-anal Application of Topical Oxymetazoline Gel in Healthy Adult Volunteers

Trial Profile

A Phase I, Open-Label, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intra-anal Application of Topical Oxymetazoline Gel in Healthy Adult Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Dec 2018

At a glance

  • Drugs Oxymetazoline (Primary)
  • Indications Faecal incontinence
  • Focus Pharmacokinetics
  • Sponsors RDD Pharma
  • Most Recent Events

    • 27 Nov 2018 Planned End Date changed from 30 Nov 2018 to 31 Mar 2019.
    • 27 Nov 2018 Planned primary completion date changed from 31 Oct 2018 to 28 Feb 2019.
    • 21 Oct 2018 Planned End Date changed from 1 Sep 2018 to 30 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top